Mirum Pharmaceuticals, Inc. (FRA:08D)

Mirum Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	282.02	222.5	286.33	28	31.34	142.09
Short-Term Investments	93.53	57.81	-	123.72	125.2	89.73
Cash & Short-Term Investments	375.55	280.32	286.33	151.72	156.54	231.82
Cash Growth	32.03%	-2.10%	88.72%	-3.08%	-32.47%	98.71%
Accounts Receivable	107.13	78.29	67.97	23.99	3.27	-
Other Receivables	-	-	-	-	0.3	-
Receivables	107.13	78.29	67.97	23.99	3.57	-
Inventory	24.02	22.4	22.31	5.57	1.51	-
Prepaid Expenses	23.87	11.78	10.94	8.95	4.97	4.53
Total Current Assets	530.58	392.79	387.54	190.23	166.59	236.35
Property, Plant & Equipment	9.78	9.81	1.99	2.35	2.55	3.24
Long-Term Investments	2.47	12.53	-	-	4.98	-
Other Intangible Assets	231.9	249.82	252.93	58.95	18.74	-
Other Long-Term Assets	10.4	5.81	4.17	101.38	101.79	1.27
Total Assets	785.12	670.75	646.62	352.91	294.65	240.86
Accounts Payable	12.17	14.62	7.42	8.69	9.17	3.15
Accrued Expenses	87.89	72.86	54.89	34.73	24.42	13.41
Current Portion of Leases	2.04	1.71	1.1	0.93	0.71	0.64
Other Current Liabilities	58.26	37.36	23.65	20.37	8.3	1.26
Total Current Liabilities	160.36	126.55	87.06	64.73	42.6	18.46
Long-Term Debt	309.37	308.08	306.42	-	-	-
Long-Term Leases	7.36	7.97	0.62	1.26	1.9	2.63
Other Long-Term Liabilities	15.98	2.51	3.85	144.88	129.94	47.68
Total Liabilities	493.07	445.11	397.95	210.87	174.44	68.77
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	953.82	870.19	803.26	535.07	377.4	345.18
Retained Earnings	-661.81	-644.18	-556.24	-392.82	-257.16	-173.17
Comprehensive Income & Other	0.04	-0.37	1.64	-0.22	-0.04	0.08
Total Common Equity	292.05	225.64	248.67	142.04	120.21	172.1
Shareholders' Equity	292.05	225.64	248.67	142.04	120.21	172.1
Total Liabilities & Equity	785.12	670.75	646.62	352.91	294.65	240.86
Total Debt	318.76	317.76	308.14	2.19	2.61	3.26
Net Cash (Debt)	56.78	-37.45	-21.82	149.53	153.93	228.56
Net Cash Growth	-	-	-	-2.86%	-32.65%	102.24%
Net Cash Per Share	1.15	-0.79	-0.53	4.40	5.08	9.05
Filing Date Shares Outstanding	51.39	49.01	47	37.95	31.73	30.42
Total Common Shares Outstanding	51.31	48.34	46.72	36.96	30.58	29.78
Working Capital	370.22	266.24	300.48	125.5	124	217.89
Book Value Per Share	5.69	4.67	5.32	3.84	3.93	5.78
Tangible Book Value	60.15	-24.18	-4.26	83.08	101.47	172.1
Tangible Book Value Per Share	1.17	-0.50	-0.09	2.25	3.32	5.78
Machinery	-	1.64	0.91	0.6	0.2	0.3
Leasehold Improvements	-	0.2	1.3	1.31	1.48	1.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.